JAK1 and enteropathy-associated T-cell lymphoma: The JAK1 and STAT3 gene mutations are observed in 90% of Enteropathy-associated T-cell lymphoma (EATL) patients and 80% of refractory celiac disease type II (RCD2) patients (8, 9).